| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.54▼ | 0.54▲ | 0.53▲ | 0.51▲ | 0.53▲ |
| MA10 | 0.54▲ | 0.53▲ | 0.53▲ | 0.50▲ | 0.56▼ |
| MA20 | 0.53▲ | 0.53▲ | 0.52▲ | 0.53▲ | 0.58▼ |
| MA50 | 0.52▲ | 0.50▲ | 0.50▲ | 0.57▼ | 0.65▼ |
| MA100 | 0.50▲ | 0.52▲ | 0.54▼ | 0.59▼ | 0.76▼ |
| MA200 | 0.52▲ | 0.57▼ | 0.57▼ | 0.62▼ | 0.92▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.000▲ | 0.002▲ | 0.003▲ | -0.004▼ |
| RSI | 71.750▲ | 67.371▲ | 64.175▲ | 51.691▲ | 44.134▼ |
| STOCH | 100.000▲ | 87.589▲ | 60.105 | 52.764 | 22.759 |
| WILL %R | 0.000▲ | 0.000▲ | -0.988▲ | -27.215 | -51.681 |
| CCI | 66.667 | 145.593▲ | 161.019▲ | 48.472 | -128.075▼ |
|
Thursday, December 04, 2025 05:32 AM
Pediatric nephrology and cardiology teams continue to seek out Aquadex for safe, precise fluid management in complex casesMINNEAPOLIS, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), ...
|
|
Wednesday, December 03, 2025 06:17 AM
How to Streamline Cell Therapy Innovation, Not Compromising the Level of Evidence The CVCT Multi-Stakeholder Think Tank Debate Dr. Nataliya Agafonova, Panelist ...
|
|
Tuesday, December 02, 2025 07:56 AM
Pedmark cut cisplatin-related hearing loss in a Japan trial, with strong safety and no impact on tumor response, supporting plans for Japan registration.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/12/25 | 0.534 | 0.547 | 0.51 | 0.547 | 140,800 |
| 03/12/25 | 0.491 | 0.555 | 0.491 | 0.529 | 156,100 |
| 02/12/25 | 0.50 | 0.521 | 0.475 | 0.504 | 89,400 |
| 01/12/25 | 0.455 | 0.505 | 0.455 | 0.495 | 124,200 |
| 28/11/25 | 0.495 | 0.495 | 0.432 | 0.455 | 287,600 |
| 26/11/25 | 0.485 | 0.49 | 0.472 | 0.48 | 66,200 |
| 25/11/25 | 0.471 | 0.494 | 0.465 | 0.47 | 99,500 |
| 24/11/25 | 0.517 | 0.517 | 0.446 | 0.464 | 786,700 |
| 21/11/25 | 0.516 | 0.542 | 0.512 | 0.514 | 50,200 |
| 20/11/25 | 0.51 | 0.527 | 0.51 | 0.514 | 73,400 |
|
|
||||
|
|
||||
|
|